PS128. Ketamine R(-) and S(+) Pharmacological Actions; Together or Separate Rapid Acting Antidepressants
نویسنده
چکیده
s | 43 PS126 DAPK1 interaction with NMDA receptor NR2B subunit underlies the rapid antidepressant effect Ling-Zhi Xu,1,2,# Su-Xia Li,2,# Ying Han 1,2,#, Ruo-Xi Zhang,1,2 Lin Lu 1,2,3 1Institute of Mental Health/Peking University Sixth Hospital and Key Laboratory of Mental Health, Ministry of Health, Beijing, China; 2National Institute on Drug Dependence, Peking University, Beijing, China; 3Peking-Tsinghua Center for Life Sciences and PKU-IDG/ McGovern Institute for Brain Research; # Equal contribution to this
منابع مشابه
Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants
Newer antidepressants are needed for the many individuals with major depressive disorder (MDD) that do not respond adequately to treatment and because of a delay of weeks before the emergence of therapeutic effects. Recent evidence from clinical trials shows that the NMDA antagonist ketamine is a revolutionary novel antidepressant because it acts rapidly and is effective for treatment-resistant...
متن کاملRapid-acting glutamatergic antidepressants: the path to ketamine and beyond.
Traditional antidepressants require many weeks to reveal their therapeutic effects. However, the widely replicated observation that a single subanesthetic dose of the N-methyl-D-aspartate glutamate receptor antagonist ketamine produced meaningful clinical improvement within hours, suggested that rapid-acting antidepressants might be possible. The ketamine studies stimulated a new generation of ...
متن کاملKetamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeutics.
Ketamine is the prototype for a new generation of glutamate-based antidepressants that rapidly alleviate depression within hours of treatment. Over the past decade, there has been replicated evidence demonstrating the rapid and potent antidepressant effects of ketamine in treatment-resistant depression. Moreover, preclinical and biomarker studies have begun to elucidate the mechanism underlying...
متن کاملmGluR2/3 blockade produces rapid and long-lasting reversal of anhedonia caused by chronic stress exposure
BACKGROUND Depression is a prevalent neuropsychiatric disorder that affects an estimated 350 million people worldwide. Currently available treatments for depression are lacking in both speed of onset and efficacy. Recent pharmacological efforts have targeted the glutamatergic neurotransmitter system using the N-methyl-D-aspartate (NMDA) receptor antagonist ketamine to produce rapid and robust a...
متن کاملRapid Acting Antidepressants in Chronic Stress Models: Molecular and Cellular Mechanisms
Stress-associated disorders, including depression and anxiety, impact nearly 20% of individuals in the United States. The social, health, and economic burden imposed by stress-associated disorders requires in depth research efforts to identify suitable treatment strategies. Traditional medications (e.g., selective serotonin reuptake inhibitors, monoamine oxidase inhibitors) have significant lim...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 19 شماره
صفحات -
تاریخ انتشار 2016